Rivastigmine Tartrate
Who holds supplier records for Rivastigmine Tartrate? 19 organisations hold a current record for Rivastigmine Tartrate: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 10 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (12), Iceland (1), Canada (1), Italy (1) and 4 other countries (4).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Rivastigmine Tartrate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/rivastigmine-tartrate
Reading the evidence
- 19 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
12 of the 19 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 14 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (19)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Rivastigmine Tartrate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 17249, 21781 · latest filing Jul 2008
- MSN Organics Private LimitedIndiaCEPActive DMF 35776, 28073 · latest filing Mar 2021
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 21800 · latest filing Jun 2008
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 24086 · latest filing Aug 2010
- Cipla LimitedIndiaCEP Company GMP cert on recordActive DMF 17064 · latest filing Dec 2003
- AARTI DRUGS LTDIndia Company GMP cert on recordActive DMF 22997 · latest filing Jul 2009
- ACTAVIS GROUP PTC EHFIceland Company GMP cert on recordActive DMF 23265 · latest filing Nov 2009
- Apotex Inc.CanadaActive DMF 22252 · latest filing Dec 2008
- ERREGIERRE SPAItaly Company GMP cert on recordActive DMF 20227 · latest filing Jan 2007
- JUBILANT BIOSYS LTDIndiaActive DMF 24501 · latest filing Mar 2011
- Macleods Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 24153 · latest filing Sept 2010
- ORBION PHARMACEUTICALS PRIVATE LTDIndia Company GMP cert on recordActive DMF 20753 · latest filing Aug 2007
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 17289 · latest filing Apr 2004
- Wuxi Fortune Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 40830 · latest filing Apr 2025
- SwedenCEP Company GMP cert on record
- IndiaCEP
- SlovakiaCEP Company GMP cert on record
- IndiaCEP
- INTERQUIM SAPeruCEP Company GMP cert on recordInactive DMF 22773 · latest filing May 2009
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (10)
Certificates of Suitability on the EDQM register for Rivastigmine Tartrate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 13 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | CEP 2021-248 - Rev 01 Rivastigmine hydrogen tartrate, Process – I | Oct 2026 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy | IN | CEP 2013-003 - Rev 05 Rivastigmine hydrogen tartrate | Jul 2026 | — |
| CIPLA LIMITED Mumbai | IN | CEP 2014-053 - Rev 01 Rivastigmine hydrogen tartrate | Aug 2025 | — |
| SHODHANA LABORATORIES PRIVATE LIMITED Hyderabad | IN | CEP 2019-066 - Rev 02 Rivastigmine hydrogen tartrate | Jun 2025 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | CEP 2013-069 - Rev 01 Rivastigmine hydrogen tartrate | Feb 2025 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2012-295 - Rev 01 Rivastigmine hydrogen tartrate | Nov 2023 | — |
| SANECA PHARMACEUTICALS A.S. Hlohovec | SK | R0-CEP 2023-074 - Rev 00 Rivastigmine hydrogen tartrate, Process 2 | May 2023 | — |
| CAMBREX KARLSKOGA AB Karlskoga | SE | R1-CEP 2014-292 - Rev 00 Rivastigmine hydrogen tartrate | May 2021 | — |
| MSN ORGANICS PRIVATE LIMITED Bibinagar Village | IN | R1-CEP 2015-055 - Rev 00 Rivastigmine hydrogen tartrate | May 2021 | — |
| Interquim, S.A. Sant Cugat Del Vallès | ES | R1-CEP 2013-331 - Rev 00 Rivastigmine hydrogen tartrate | Jan 2020 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (4)
Organisations whose Type II DMFs for Rivastigmine Tartrate are no longer active. These show a past filing, not current supply.
Show all 4 historical records
- MYLAN LABORATORIES LTDInactive DMF 24442 · filed Dec 2010
- Zhejiang Jiuzhou Pharmaceutical Co., Ltd.China · Inactive DMF 23346 · filed Nov 2009
- India · Inactive DMF 22249 · filed Dec 2008
- Germany · Inactive DMF 21469 · filed Mar 2008
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Rivastigmine Tartrate is an acetylcholinesterase inhibitor used for the treatment of mild to moderate dementia associated with Alzheimer's and Parkinson's disease. It works by increasing the amount of acetylcholine, a neurotransmitter involved in memory and cognition, in the brain.
Chemical identity
- IUPAC name
- (2R,3R)-2,3-dihydroxybutanedioic acid;[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate
- Canonical SMILES
- CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
- InChIKey
- GWHQHAUAXRMMOT-MBANBULQSA-N
- Synonyms
- Exelon API, ena 713, ena-713, rivastigmine (as hydrogen tartrate), rivastigmine actavis, rivastigmine bitartrate, rivastigmine hydrogen tartrate, rivastigmine hydrogentartrate, sdz-ena 713, sdz-ena-713
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Cholinesterase Inhibitor
- Mechanism of action
- Cholinesterase Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Rivastigmine Tartrate?
19 organisations hold an active US FDA Type II Drug Master File or a CEP for Rivastigmine Tartrate: Dr. Reddy's Laboratories Ltd. (India), MSN Organics Private Limited (India), Alembic Pharmaceuticals Limited (India), APITORIA PHARMA PRIVATE LTD (India), Cipla Limited (India), AARTI DRUGS LTD (India), ACTAVIS GROUP PTC EHF (Iceland) and Apotex Inc. (Canada), and 11 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Rivastigmine Tartrate Drug Master Files are active?
Dr. Reddy's Laboratories Ltd. (DMF 17249, 21781), MSN Organics Private Limited (DMF 35776, 28073), Alembic Pharmaceuticals Limited (DMF 21800), APITORIA PHARMA PRIVATE LTD (DMF 24086), Cipla Limited (DMF 17064), AARTI DRUGS LTD (DMF 22997), ACTAVIS GROUP PTC EHF (DMF 23265) and Apotex Inc. (DMF 22252) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Rivastigmine Tartrate records mean?
4 organisations have only inactive Type II DMFs for Rivastigmine Tartrate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Rivastigmine Tartrate have a European Certificate of Suitability?
Yes. 10 organisations hold a valid CEP for Rivastigmine Tartrate on the EDQM register, including DR. REDDY'S LABORATORIES LIMITED Hyderabad (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), CIPLA LIMITED Mumbai (IN), SHODHANA LABORATORIES PRIVATE LIMITED Hyderabad (IN), ALEMBIC PHARMACEUTICALS LIMITED Vadodara (IN) and APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Rivastigmine Tartrate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Rivastigmine Tartrate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.